AWMDMG
ARGS

Austin W. Marxe & David M. Greenhouse’s Argos Therapeutics, Inc. ARGS Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ARGS Stock Details ARGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7.54M Hold
37,500
– – 1.03% 30
2014
Q2 		$6.02M Hold
37,500
– – 0.76% 48
2014
Q1 		$7.5M Buy
+37,500
New +$7.5M 0.83% 40

Other funds holding ARGS

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ARGS Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Argos Therapeutics, Inc. (ARGS) position steady in Q3 2014 at 37,500 shares worth $7.54M. The position accounts for 1.03% of the portfolio, ranked #30.

Austin W. Marxe & David M. Greenhouse first reported a position in ARGS in Q1 2014 and has held it in 3 quarters since. 26 funds tracked by Wall St. Rank hold ARGS as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 37,500 shares of Argos Therapeutics, Inc. worth $7.54M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse left its Argos Therapeutics, Inc. share count unchanged in Q3 2014.
  • Argos Therapeutics, Inc. made up 1.03% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #30 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Argos Therapeutics, Inc. in Q1 2014 and has held it in 3 quarters since.
  • 26 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.